These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 19539619)

  • 1. The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro.
    Luca T; Di Benedetto G; Scuderi MR; Palumbo M; Clementi S; Bernardini R; Cantarella G
    Eur J Pharmacol; 2009 Aug; 616(1-3):16-21. PubMed ID: 19539619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the CB
    Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
    BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antimitogenic effect of the cannabinoid receptor agonist WIN55212-2 on human melanoma cells is mediated by the membrane lipid raft.
    Scuderi MR; Cantarella G; Scollo M; Lempereur L; Palumbo M; Saccani-Jotti G; Bernardini R
    Cancer Lett; 2011 Nov; 310(2):240-9. PubMed ID: 21807457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
    Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM
    Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.
    Qamri Z; Preet A; Nasser MW; Bass CE; Leone G; Barsky SH; Ganju RK
    Mol Cancer Ther; 2009 Nov; 8(11):3117-29. PubMed ID: 19887554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development.
    Shoeib AM; Yarbrough AL; Ford BM; Franks LN; Urbaniak A; Hensley LL; Benson LN; Mu S; Radominska-Pandya A; Prather PL
    Life Sci; 2021 Nov; 285():119993. PubMed ID: 34592231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid agonists inhibit neuropathic pain induced by brachial plexus avulsion in mice by affecting glial cells and MAP kinases.
    Paszcuk AF; Dutra RC; da Silva KA; Quintão NL; Campos MM; Calixto JB
    PLoS One; 2011; 6(9):e24034. PubMed ID: 21931637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cannabinoid WIN 55,212-2-mediated protection of dentate gyrus granule cells is driven by CB1 receptors and modulated by TRPA1 and Cav 2.2 channels.
    Koch M; Kreutz S; Böttger C; Grabiec U; Ghadban C; Korf HW; Dehghani F
    Hippocampus; 2011 May; 21(5):554-64. PubMed ID: 20135626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid CB(2) receptor activation prevents bronchoconstriction and airway oedema in a model of gastro-oesophageal reflux.
    Cui YY; D'Agostino B; Risse PA; Marrocco G; Naline E; Zhang Y; Chen HZ; Finance O; Rinaldi-Carmona M; Rossi F; Advenier C
    Eur J Pharmacol; 2007 Nov; 573(1-3):206-13. PubMed ID: 17643417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. R-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo-[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphtalenylmethanone (WIN-2) ameliorates experimental autoimmune encephalomyelitis and induces encephalitogenic T cell apoptosis: partial involvement of the CB(2) receptor.
    Sánchez AJ; González-Pérez P; Galve-Roperh I; García-Merino A
    Biochem Pharmacol; 2006 Dec; 72(12):1697-706. PubMed ID: 17007821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CB1- and CB2-cannabinoid receptor-independent lipolysis induced by WIN 55,212-2 in male rat adipocytes.
    Nieri P; Greco R; Adinolfi B; Breschi MC; Martinotti E; Nannetti C; Podestà A
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):352-9. PubMed ID: 14566452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid/agonist WIN 55,212-2 reduces cardiac ischaemia–reperfusion injury in Zucker diabetic fatty rats: role of CB2 receptors and iNOS/eNOS.
    González C; Herradón E; Abalo R; Vera G; Pérez-Nievas BG; Leza JC; Martín MI; López-Miranda V
    Diabetes Metab Res Rev; 2011 May; 27(4):331-40. PubMed ID: 21309057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway.
    Fakhfouri G; Ahmadiani A; Rahimian R; Grolla AA; Moradi F; Haeri A
    Neuropharmacology; 2012 Sep; 63(4):653-66. PubMed ID: 22634229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoids stimulate fibroblastic colony formation by bone marrow cells indirectly via CB2 receptors.
    Scutt A; Williamson EM
    Calcif Tissue Int; 2007 Jan; 80(1):50-9. PubMed ID: 17205329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis.
    Preet A; Qamri Z; Nasser MW; Prasad A; Shilo K; Zou X; Groopman JE; Ganju RK
    Cancer Prev Res (Phila); 2011 Jan; 4(1):65-75. PubMed ID: 21097714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The endocannabinoid receptors CB1 and CB2 affect the regenerative potential of adipose tissue MSCs.
    Ruhl T; Karthaus N; Kim BS; Beier JP
    Exp Cell Res; 2020 Apr; 389(1):111881. PubMed ID: 32006556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.
    Mulè F; Amato A; Baldassano S; Serio R
    Pharmacol Res; 2007 Sep; 56(3):185-92. PubMed ID: 17656103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Fas receptor/Fas-associated protein with death domain apoptotic complex and associated signalling systems by cannabinoid receptors in the mouse brain.
    Alvaro-Bartolomé M; Esteban S; García-Gutiérrez MS; Manzanares J; Valverde O; García-Sevilla JA
    Br J Pharmacol; 2010 Jun; 160(3):643-56. PubMed ID: 20590568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat: role of CB1 receptors.
    Abalo R; Cabezos PA; Vera G; López-Miranda V; Herradón E; Martín-Fontelles MI
    Neurogastroenterol Motil; 2011 May; 23(5):457-67, e177. PubMed ID: 21303434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
    McMahon LR
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1211-8. PubMed ID: 16943255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.